Neovacs S.A. (EPA:ALNEV)
France · Delayed Price · Currency is EUR 0.6120
-0.0680 (-10.00%)
Aug 21, 2026, 5:35 PM CET
Neovacs Market Cap
Neovacs has a market cap or net worth of €97.35 thousand as of August 21, 2026. Its market cap has decreased by -72.39% in one year.
Market Cap
97.35K
Enterprise Value
229.50K
Revenue
199.27K
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.61
ChartMarket Cap Chart
Since June 2, 2025, Neovacs's market cap has decreased from 600.00K to 97.35K, a decrease of -83.78%. That is a compound annual growth rate of -77.50%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 97.35K | 2,280.70% |
| Dec 31, 2025 | 4.09K | -99.32% |
| Jun 2, 2025 | 600.00K | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| genOway Société anonyme | 22.68M |
| Aelis Farma | 14.41M |
| Aton | 12.59M |
| NFL Biosciences | 11.23M |
| Poxel | 10.49M |
| Biophytis | 9.62M |
| TME Pharma | 8.39M |
| Oncodesign Precision Medicine Société anonyme | 6.11M |